Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

The normal human prostate does not significantly affect blood DHT levels.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

DHEA may play a complex role in PCOS, affecting hormones, metabolism, and symptoms.

Oral contraceptives are generally recommended for healthy young girls, but specific types may vary based on individual health conditions and barrier methods are less popular among adolescents.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Antiandrogens and finasteride may help treat excess hair and hair loss in women.

Higher DHEA-S levels are linked to smaller ovarian volume in women with PCOS.

Neurosteroids like allopregnanolone help control cell death and growth in the developing fetal brain.

Glucocorticoid treatment lowered androgen levels but didn't improve hirsutism or ovulation and caused weight gain.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

Bimatoprost effectively promotes hair growth.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Prostaglandin D2 increases testosterone levels in skin cells through reactive oxygen species, not enzymes, which could lead to new hair loss treatments.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Reference values for nine hormones were established to help diagnose PCOS.

Tiny lipid particles carrying 17-α-estradiol gather in hair follicles, which may help target alopecia treatment.

1 alpha,25-dihydroxy-vitamin D3 and calcipotriol speed up cell differentiation in hair follicles.